TAM
KALA icon

Tiverton Asset Management’s KALA BIO KALA Stock Holding History

Tiverton Asset Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5
Closed -$157K – 417
2018
Q2 		$157K Hold
5
– – 0.01% 340
2018
Q1 		$186K Buy
+5
New +$190K 0.01% 327

Other funds holding KALA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tiverton Asset Management's KALA Position: Q3 2018 in Review

Tiverton Asset Management sold out of KALA BIO (KALA) in Q3 2018, closing a stake of 5 shares — an estimated $157K sold.

Tiverton Asset Management first reported a position in KALA in Q1 2018 and held it in 2 quarters. The position peaked at $186K in Q1 2018. 59 funds tracked by Wall St. Rank hold KALA as of Q3 2018.

  • Tiverton Asset Management reported no remaining KALA BIO position as of Q3 2018 after selling out during the quarter.
  • Tiverton Asset Management sold 5 KALA BIO shares in Q3 2018, an estimated $157K.
  • Tiverton Asset Management first reported a position in KALA BIO in Q1 2018 and held it in 2 quarters.
  • Tiverton Asset Management's KALA BIO position peaked at $186K in Q1 2018.
  • 59 funds tracked by Wall St. Rank held KALA BIO as of Q3 2018.

Based on Tiverton Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.